How Ehlers-Danlos Syndrome Affects Gynaecological Health
Official title: Impact of Ehlers-Danlos Syndrome on Gynaecological Health: Focus on the Prevalence of Dysmenorrhoea
Run by University Hospital, Rouen · NCT07151274 · Data updated 2026-11-12
This study will test whether women with EDS have more severe dysmenorrhea and other gynecologic issues than women without EDS.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | Women only |
| Enrollment | 156 (estimated) |
| Sponsor | University Hospital, Rouen Academic / other |
| Locations | 1 site (Rouen) |
| Status | Recruiting |
| Started | July 7, 2025 |
| Main results expected | July 1, 2026 |
| Study ends | August 1, 2026 |
| Registry record updated | June 10, 2026 |
| Trial ID | NCT07151274 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are adults 18+ with or without EDS who can complete an online French questionnaire.
✕Probably not a fit
Results may be less informative for individuals who do not fit the study groups or who experience very atypical gynecologic symptoms.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study compares the severity of menstrual pain and the prevalence of gynecologic conditions between women with EDS and a control group. Participants will complete an online questionnaire to report symptoms, medical history, and reproductive health experiences. The aim is to better characterise how EDS may influence menstrual pain, bleeding, and related conditions. The study is led by University Hospital, Rouen, and uses an online, voluntary participation approach.
Why it matters
Potential benefit: If successful, findings could help tailor gynecologic care for people with EDS.
How similar studies have gone: Previous work suggests higher rates of gynecologic issues in EDS, but comparative data are limited and results have varied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women aged 18 or over. * Willing to participate voluntarily in the study via an online questionnaire. * Of childbearing age. * Reporting a diagnosis of EDS (all types) or not having EDS (control group) and being part of a database of healthy volunteers. Exclusion Criteria: * Minors (\< 18 years old). * Menopausal women * People who do not understand French well enough to complete the questionnaire. * Uncertain diagnosis of EDS (exclusion of participants who suspect EDS but without medical confirmation).
Where it's running
-
CHU de ROUEN
Rouen, France Recruiting
Study contacts
- Study coordinator: Mathilde ML LECOINTRE, Doctor
- Email: melodie.lecointre@chu-rouen.fr
- Phone: 02 32 88 07 89
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Stable Pilates for hypermobility symptoms
This study tests whether six weeks of Pilates-led by a licensed physical therapist can reduce pain and related symptoms in adults with hypermobility conditions like hEDS/HSD.
-
Pregnancy-Related Aortic Dissection in China
This study looks at cases of aortic dissection that occur during pregnancy or shortly after, to understand outcomes for mothers and babies.
-
Metabolic testing in people with vascular Ehlers-Danlos syndrome
This project will test whether people with vascular Ehlers-Danlos syndrome have problems with how their bodies store and use fat that could lead to insulin resistance or diabetes.
-
Heart Coherence Training for Patients with Vascular Ehlers-Danlos Syndrome
This study is testing an 8-week online program to see if heart coherence training can help people with Vascular Ehlers-Danlos Syndrome manage stress and anxiety better.
-
Comparing Celiprolol to Placebo for Vascular Ehlers-Danlos Syndrome
This study is testing whether the medication celiprolol can help people with Vascular Ehlers-Danlos Syndrome feel better compared to a placebo.
-
A platform for collecting health data on ME/CFS and Long Covid
This study is trying to collect health information from adults with ME/CFS and Long Covid to help researchers better understand these conditions and improve future treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.